Novartis Investigative Site

Cagliari, CA 09134

0 studies enrolling now · 6 studies all time

What they study most

Chronic Spontaneous Urticaria, HER2+ Breast Cancer, Metastatic Breast Cancer, Multiple Sclerosis, Myelodysplastic Syndromes, RRMS, Relapsing Forms of Multiple Sclerosis

Studies at this site

• A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. — Completed
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study — Completed
• Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis — Completed
• Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer — Stopped early